STOCK TITAN

Jennifer Michaelson sells shares under 10b5-1 (CGEM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jennifer Michaelson reported multiple 10b5-1 sales of common stock under Form 144, covering transactions from 12/12/2025 through 02/23/2026. The filing lists several dispositions, including 8,000 shares on 02/20/2026 and 1,752 shares on 02/23/2026.

Positive

  • None.

Negative

  • None.

Insights

Planned 10b5-1 sales by an insider across multiple dates; routine disclosure.

The filing lists sequential dispositions of common stock by Jennifer Michaelson under a 10b5-1 arrangement, with executed trades between 12/12/2025 and 02/23/2026

These entries are transactional records; cash‑flow recipients are the selling person. Subsequent filings may report further executions or settlement details.

Disclosure aligns with routine insider-sale reporting obligations, not a corporate action.

The entries document dispositions and dates, showing the mechanism as 10b5-1 sales. The filing does not state any company-directed sale or corporate issuance.

Review future Forms 4/144 for additional volumes or changes to trading plans.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Jennifer Michaelson report in the Form 144 for CGEM?

The Form 144 reports multiple 10b5-1 sales of common stock by Jennifer Michaelson. The listed transactions span 12/12/2025 to 02/23/2026, showing executed dispositions on specific trade dates and share counts.

How many shares are shown in the largest individual sale listed?

The largest single sale shown in the excerpt is 8,000 shares on 02/20/2026. The filing itemizes individual trade dates and share counts rather than an aggregated total for all transactions.

Were these sales made under a trading plan or as open market trades?

The excerpt identifies the transactions as 10b5-1 sales, indicating they were executed under a prearranged trading plan. The filing lists each trade date and share amount tied to that plan.

Does the Form 144 show proceeds received by the company?

No. The entries record insider dispositions of common stock; they list share counts and trade dates. The filing does not state any proceeds being received by the issuer or changes to company capital accounts.

What date range do the reported transactions cover in this filing?

The reported transactions in the excerpt cover trade dates from 12/12/2025 through 02/23/2026, with multiple discrete sales recorded on those dates.
Cullinan Oncology Inc

NASDAQ:CGEM

CGEM Rankings

CGEM Latest News

CGEM Latest SEC Filings

CGEM Stock Data

898.55M
56.27M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE